UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN, E9
Agrees to be Acquired
Dr. Áine Miller to Depart as SVP of Development on November 15, 2026
2026 Annual Meeting Results - Directors Elected for Theravance Biopharma
Earnings Release
Other Events
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Reports Phase 3 CYPRESS Study Did Not Meet Primary Endpoint; Board Accelerates Strategic Review and Announces Cost Reduction Actions
Corporate Presentation January 2026
Q1
FY 2025
Q3
Q2
FY 2024
SC TO-I
Tender Offer Statement by Issuer
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Tender Offer Statement by Issuer
Correspondence